Clinical Trial Update: Surgical Pembro +/- Olaparib w TMZ for rGBM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is recruiting to evaluate pembrolizumab with or without olaparib and temozolomide for recurrent glioblastoma, including a surgical compon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Lynparza (olaparib)
• Temodar (Temozolomide)

Snippet

Sponsor: L. Nicolas Gonzalez Castro, MD, PhD | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 2 | Status: RECRUITING